Table of Content

1 Serplulimab Injection Market Overview
1.1 Product Overview and Scope of Serplulimab Injection
1.2 Serplulimab Injection Segment by Type
1.2.1 Global Serplulimab Injection Market Value Comparison by Type (2024-2034)
1.2.2 100mg/10ml
1.2.3 Others
1.3 Serplulimab Injection Segment by Application
1.3.1 Global Serplulimab Injection Market Value by Application: (2024-2034)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Serplulimab Injection Market Size Estimates and Forecasts
1.4.1 Global Serplulimab Injection Revenue 2018-2029
1.4.2 Global Serplulimab Injection Sales 2018-2029
1.4.3 Global Serplulimab Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Serplulimab Injection Market Competition by Manufacturers
2.1 Global Serplulimab Injection Sales Market Share by Manufacturers (2018-2024)
2.2 Global Serplulimab Injection Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Serplulimab Injection Average Price by Manufacturers (2018-2024)
2.4 Global Serplulimab Injection Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Serplulimab Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Serplulimab Injection, Product Type & Application
2.7 Serplulimab Injection Market Competitive Situation and Trends
2.7.1 Serplulimab Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Serplulimab Injection Players Market Share by Revenue
2.7.3 Global Serplulimab Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Serplulimab Injection Retrospective Market Scenario by Region
3.1 Global Serplulimab Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Serplulimab Injection Global Serplulimab Injection Sales by Region: 2018-2029
3.2.1 Global Serplulimab Injection Sales by Region: 2018-2024
3.2.2 Global Serplulimab Injection Sales by Region: 2024-2029
3.3 Global Serplulimab Injection Global Serplulimab Injection Revenue by Region: 2018-2029
3.3.1 Global Serplulimab Injection Revenue by Region: 2018-2024
3.3.2 Global Serplulimab Injection Revenue by Region: 2024-2029
3.4 North America Serplulimab Injection Market Facts & Figures by Country
3.4.1 North America Serplulimab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Serplulimab Injection Sales by Country (2018-2029)
3.4.3 North America Serplulimab Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Serplulimab Injection Market Facts & Figures by Country
3.5.1 Europe Serplulimab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Serplulimab Injection Sales by Country (2018-2029)
3.5.3 Europe Serplulimab Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Serplulimab Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Serplulimab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Serplulimab Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Serplulimab Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Serplulimab Injection Market Facts & Figures by Country
3.7.1 Latin America Serplulimab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Serplulimab Injection Sales by Country (2018-2029)
3.7.3 Latin America Serplulimab Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Serplulimab Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Serplulimab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Serplulimab Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Serplulimab Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Serplulimab Injection Sales by Type (2018-2029)
4.1.1 Global Serplulimab Injection Sales by Type (2018-2024)
4.1.2 Global Serplulimab Injection Sales by Type (2024-2029)
4.1.3 Global Serplulimab Injection Sales Market Share by Type (2018-2029)
4.2 Global Serplulimab Injection Revenue by Type (2018-2029)
4.2.1 Global Serplulimab Injection Revenue by Type (2018-2024)
4.2.2 Global Serplulimab Injection Revenue by Type (2024-2029)
4.2.3 Global Serplulimab Injection Revenue Market Share by Type (2018-2029)
4.3 Global Serplulimab Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Serplulimab Injection Sales by Application (2018-2029)
5.1.1 Global Serplulimab Injection Sales by Application (2018-2024)
5.1.2 Global Serplulimab Injection Sales by Application (2024-2029)
5.1.3 Global Serplulimab Injection Sales Market Share by Application (2018-2029)
5.2 Global Serplulimab Injection Revenue by Application (2018-2029)
5.2.1 Global Serplulimab Injection Revenue by Application (2018-2024)
5.2.2 Global Serplulimab Injection Revenue by Application (2024-2029)
5.2.3 Global Serplulimab Injection Revenue Market Share by Application (2018-2029)
5.3 Global Serplulimab Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Shanghai Henlius Biotech
6.1.1 Shanghai Henlius Biotech Corporation Information
6.1.2 Shanghai Henlius Biotech Description and Business Overview
6.1.3 Shanghai Henlius Biotech Serplulimab Injection Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Shanghai Henlius Biotech Serplulimab Injection Product Portfolio
6.1.5 Shanghai Henlius Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Serplulimab Injection Industry Chain Analysis
7.2 Serplulimab Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Serplulimab Injection Production Mode & Process
7.4 Serplulimab Injection Sales and Marketing
7.4.1 Serplulimab Injection Sales Channels
7.4.2 Serplulimab Injection Distributors
7.5 Serplulimab Injection Customers
8 Serplulimab Injection Market Dynamics
8.1 Serplulimab Injection Industry Trends
8.2 Serplulimab Injection Market Drivers
8.3 Serplulimab Injection Market Challenges
8.4 Serplulimab Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Serplulimab Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Serplulimab Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Serplulimab Injection Market Competitive Situation by Manufacturers in 2022
Table 4. Global Serplulimab Injection Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Serplulimab Injection Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Serplulimab Injection Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Serplulimab Injection Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Serplulimab Injection Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Serplulimab Injection, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Serplulimab Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Serplulimab Injection, Product Type & Application
Table 12. Global Key Manufacturers of Serplulimab Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Serplulimab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Serplulimab Injection as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Serplulimab Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Serplulimab Injection Sales by Region (2018-2024) & (K Units)
Table 18. Global Serplulimab Injection Sales Market Share by Region (2018-2024)
Table 19. Global Serplulimab Injection Sales by Region (2024-2029) & (K Units)
Table 20. Global Serplulimab Injection Sales Market Share by Region (2024-2029)
Table 21. Global Serplulimab Injection Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Serplulimab Injection Revenue Market Share by Region (2018-2024)
Table 23. Global Serplulimab Injection Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Serplulimab Injection Revenue Market Share by Region (2024-2029)
Table 25. North America Serplulimab Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Serplulimab Injection Sales by Country (2018-2024) & (K Units)
Table 27. North America Serplulimab Injection Sales by Country (2024-2029) & (K Units)
Table 28. North America Serplulimab Injection Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Serplulimab Injection Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Serplulimab Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Serplulimab Injection Sales by Country (2018-2024) & (K Units)
Table 32. Europe Serplulimab Injection Sales by Country (2024-2029) & (K Units)
Table 33. Europe Serplulimab Injection Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Serplulimab Injection Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Serplulimab Injection Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Serplulimab Injection Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Serplulimab Injection Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Serplulimab Injection Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Serplulimab Injection Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Serplulimab Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Serplulimab Injection Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Serplulimab Injection Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Serplulimab Injection Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Serplulimab Injection Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Serplulimab Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Serplulimab Injection Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Serplulimab Injection Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Serplulimab Injection Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Serplulimab Injection Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Serplulimab Injection Sales (K Units) by Type (2018-2024)
Table 51. Global Serplulimab Injection Sales (K Units) by Type (2024-2029)
Table 52. Global Serplulimab Injection Sales Market Share by Type (2018-2024)
Table 53. Global Serplulimab Injection Sales Market Share by Type (2024-2029)
Table 54. Global Serplulimab Injection Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Serplulimab Injection Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Serplulimab Injection Revenue Market Share by Type (2018-2024)
Table 57. Global Serplulimab Injection Revenue Market Share by Type (2024-2029)
Table 58. Global Serplulimab Injection Price (US$/Unit) by Type (2018-2024)
Table 59. Global Serplulimab Injection Price (US$/Unit) by Type (2024-2029)
Table 60. Global Serplulimab Injection Sales (K Units) by Application (2018-2024)
Table 61. Global Serplulimab Injection Sales (K Units) by Application (2024-2029)
Table 62. Global Serplulimab Injection Sales Market Share by Application (2018-2024)
Table 63. Global Serplulimab Injection Sales Market Share by Application (2024-2029)
Table 64. Global Serplulimab Injection Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Serplulimab Injection Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Serplulimab Injection Revenue Market Share by Application (2018-2024)
Table 67. Global Serplulimab Injection Revenue Market Share by Application (2024-2029)
Table 68. Global Serplulimab Injection Price (US$/Unit) by Application (2018-2024)
Table 69. Global Serplulimab Injection Price (US$/Unit) by Application (2024-2029)
Table 70. Shanghai Henlius Biotech Corporation Information
Table 71. Shanghai Henlius Biotech Description and Business Overview
Table 72. Shanghai Henlius Biotech Serplulimab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Shanghai Henlius Biotech Serplulimab Injection Product
Table 74. Shanghai Henlius Biotech Recent Developments/Updates
Table 75. Key Raw Materials Lists
Table 76. Raw Materials Key Suppliers Lists
Table 77. Serplulimab Injection Distributors List
Table 78. Serplulimab Injection Customers List
Table 79. Serplulimab Injection Market Trends
Table 80. Serplulimab Injection Market Drivers
Table 81. Serplulimab Injection Market Challenges
Table 82. Serplulimab Injection Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Serplulimab Injection
Figure 2. Global Serplulimab Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Serplulimab Injection Market Share by Type in 2022 & 2029
Figure 4. 100mg/10ml Product Picture
Figure 5. Others Product Picture
Figure 6. Global Serplulimab Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Serplulimab Injection Market Share by Application in 2022 & 2029
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Global Serplulimab Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Serplulimab Injection Market Size (2018-2029) & (US$ Million)
Figure 13. Global Serplulimab Injection Sales (2018-2029) & (K Units)
Figure 14. Global Serplulimab Injection Average Price (US$/Unit) & (2018-2029)
Figure 15. Serplulimab Injection Report Years Considered
Figure 16. Serplulimab Injection Sales Share by Manufacturers in 2022
Figure 17. Global Serplulimab Injection Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Serplulimab Injection Players: Market Share by Revenue in 2022
Figure 19. Serplulimab Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Serplulimab Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Serplulimab Injection Sales Market Share by Country (2018-2029)
Figure 22. North America Serplulimab Injection Revenue Market Share by Country (2018-2029)
Figure 23. United States Serplulimab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Serplulimab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Serplulimab Injection Sales Market Share by Country (2018-2029)
Figure 26. Europe Serplulimab Injection Revenue Market Share by Country (2018-2029)
Figure 27. Germany Serplulimab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Serplulimab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Serplulimab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Serplulimab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Serplulimab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Serplulimab Injection Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Serplulimab Injection Revenue Market Share by Region (2018-2029)
Figure 34. China Serplulimab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Serplulimab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Serplulimab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Serplulimab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Serplulimab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Serplulimab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Serplulimab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America Serplulimab Injection Sales Market Share by Country (2018-2029)
Figure 42. Latin America Serplulimab Injection Revenue Market Share by Country (2018-2029)
Figure 43. Mexico Serplulimab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil Serplulimab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina Serplulimab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Serplulimab Injection Sales Market Share by Country (2018-2029)
Figure 47. Middle East & Africa Serplulimab Injection Revenue Market Share by Country (2018-2029)
Figure 48. Turkey Serplulimab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Serplulimab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. UAE Serplulimab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Global Sales Market Share of Serplulimab Injection by Type (2018-2029)
Figure 52. Global Revenue Market Share of Serplulimab Injection by Type (2018-2029)
Figure 53. Global Serplulimab Injection Price (US$/Unit) by Type (2018-2029)
Figure 54. Global Sales Market Share of Serplulimab Injection by Application (2018-2029)
Figure 55. Global Revenue Market Share of Serplulimab Injection by Application (2018-2029)
Figure 56. Global Serplulimab Injection Price (US$/Unit) by Application (2018-2029)
Figure 57. Serplulimab Injection Value Chain
Figure 58. Serplulimab Injection Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed